Global Live Cell Imaging Market is valued approximately at USD 1.91 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 9.0% over the forecast period 2019-2026. Live cell imaging can be defined as the study of living cells via analysis systems or high content screening and imaging systems such as cell analyzers, microscopes and many more. These technologies are utilized in number of investigations that offer critical insights into the essential nature of tissue and cellular function. The live cell imaging system hasis become gradually more popular in the healthcare industry. Rising incidence of cancer, surging adoption of high-content screening techniques in drug discovery and increasing investments made in research funding are the few factors responsible for high CAGR of the market over the forecast period. For instance: In 2018, it was estimated that there were 17.0 million new cancer cases and 9.5 million cancer deaths worldwide. The global burden of cancer is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040 due to the growth and aging of the population, according to the International Agency for Research on Cancer (IARC). Thus, the prevalence of cancer is on surging trend across the globe thereby, the need for live cell imaging is expected to increase around the world. Moreover, increasing application of high content screening (HCS) in personalized medicine and growing development of new drugs are the major factors likely to create lucrative growth opportunity to the market in the upcoming years. However, high cost of high-content screening systems and the shortage of skilled professionals are few factorfactors anticipated to limiting the growth of global live cell imaging market during the forecast period.

The regional analysis of global Live Cell Imaging Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the availability of government funding for life science research, growing advancements in live cell imaging techniques and the rising incidence of cancer in the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increase in cancer prevalence, widespread outsourcing activities for research and development and growth in the demand for cancer detection techniques that would offer lucrative growth opportunities for the Live Cell Imaging market across Asia-Pacific region.

Major market player included in this report are:

  • Danaher Corporation
  • Carl Zeiss AG
  • Nikon Corporation
  • Olympus Corporation
  • Perkinelmer
  • GE Healthcare
  • Thermo Fisher Scientific
  • Sartorius AG
  • Cytosmart Technologies
  • Biotek Instruments

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product & Services:

  • Instruments
  • Consumables
  • Software
  • Services

By Application:

  • Cell Biology
  • Stem Cells
  • Developmental Biology
  • Drug Discovery

By End-User:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • Asia Pacific
  • China
  • India
  • Japan
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year – 2016, 2017
  • Base year – 2018
  • Forecast period – 2019 to 2026

Target Audience of the Global Live Cell Imaging Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors